Vaccines Facility & Manufacturing Strategy Advisor

Location: Remote (Global)
Type: Contract or Advisory

Overview:

LunaVax is building the future of local vaccine manufacturing in Africa. As our Vaccines Facility & Manufacturing Strategy Advisor, you’ll help shape the foundational blueprint for scalable, end-to-end production — from modular fill/finish operations to potential upstream integration in the future.

You’ll play a key role in advising on facility scope, design, cost modeling, and technology transfer pathways. Your insights will help align our infrastructure planning with LunaVax’s long-term goals of sustainable and flexible vaccine production.

Responsibilities:

• Guide decisions on facility scope, size, modular design, and technology selection (e.g., SUT, MAPs, sterile fill, and upstream integration potential)
• Lead early cost-of-goods (COG), CAPEX, and facility timeline estimation for scalable production
• Assess potential technology transfer partners and their alignment with LunaVax’s long-term production goals
• Advise on GMP compliance, scalable workflows, and innovations in modular and hybrid manufacturing
• Collaborate with our formulation, partnerships, and implementation teams to align infrastructure planning for phased growth

• Support long-term infrastructure planning by contributing to facility roadmaps that evolve from pilot phases to scalable, end-to-end production

Preferred Qualifications:

• 10+ years of experience in vaccine manufacturing, plant design, or bioprocess engineering
• Deep knowledge of SUT systems, modular vaccine facilities, and fill/finish tech
• Experience working on WHO prequalification or similar regulatory frameworks
• Demonstrated success supporting early-stage manufacturing projects or tech transfer initiatives

What You'll Gain:

• A defining role in launching Africa’s next-generation vaccine manufacturing platform
• The opportunity to shape GMP innovation and infrastructure from the ground up
• Direct influence on facility design that supports both fill/finish and upstream scalability
• Collaboration with global partners and local health stakeholders
• Advisory flexibility with potential for expanded involvement post-funding

Compensation:

Consulting fee or milestone-based structure, negotiable based on experience and engagement level. Flexible terms available. While LunaVax currently operates as an LLC, long-term participation incentives including potential equity upon corporate conversion may be considered for candidates aligned with our long-term vision and scale-up strategy.

Interested in this role?

We’re excited to learn more about you. Please complete the form above to share your interest. Our team carefully reviews all applications and will be in touch if your profile aligns with our current needs.

Thanks for considering LunaVax!